Algolog Prof. Dr. Emine Nur Tozan, a\u011fr\u0131 kesicilerin do\u011fru kullan\u0131m\u0131n\u0131n tedavi ba\u015far\u0131s\u0131n\u0131 art\u0131rd\u0131\u011f\u0131n\u0131 s\u00f6yledi. Kronik a\u011fr\u0131 tedavisi g\u00f6ren pek \u00e7ok hastan\u0131n sadece a\u011fr\u0131lar\u0131 oldu\u011fu zaman a\u011fr\u0131 kesici kulland\u0131\u011f\u0131na dikkat \u00e7eken Prof. Dr. Tozan, “Kronik a\u011fr\u0131 tedavisinde a\u011fr\u0131 kesiciler; \u2018a\u011fr\u0131m olduk\u00e7a al\u0131r\u0131m\u2019 \u015feklinde de\u011fil, belli bir s\u00fcre; \u2018a\u011fr\u0131 olsa da olmasa da\u2019 kural\u0131 ile devaml\u0131 ve belli bir s\u00fcrede al\u0131nmal\u0131d\u0131r” dedi.
\n
Ac\u0131badem Kent Hastanesi Algoloji (A\u011fr\u0131) Uzman\u0131 Prof. Dr. Emine Nur Tozan, a\u011fr\u0131 kesici (analjezik) ila\u00e7lar\u0131n etkili ve g\u00fcvenli kullan\u0131m\u0131n\u0131n baz\u0131 ilkelere ba\u011fl\u0131 oldu\u011funu ifade etti. Bu ilkelerin, hem k\u0131sa s\u00fcreli hem de kronik a\u011fr\u0131lar\u0131n tedavisinde komplikasyonlar\u0131 \u00f6nlemek ve en iyi sonucu almak i\u00e7in kritik \u00f6neme sahip oldu\u011funu belirten Prof. Dr. Tozan, “\u00d6zellikle 3 aydan daha uzun s\u00fcre devam eden a\u011fr\u0131lar; \u2018kronik a\u011fr\u0131\u2019 olarak tan\u0131mlan\u0131r. Kronik a\u011fr\u0131 tek ba\u015f\u0131na bir a\u011fr\u0131 olmaktan \u00f6te; hastan\u0131n ya\u015fam kalitesini de bozan multifakt\u00f6riyel bir s\u00fcre\u00e7tir. Bu nedenle bu s\u00fcreci y\u00f6netirken a\u011fr\u0131ya e\u015flik eden di\u011fer semptomlar da tedavi edilmeli ve y\u00f6netilmelidir. Kronik a\u011fr\u0131da kullan\u0131lan analjezikler, a\u011fr\u0131y\u0131 bask\u0131lamazlar, \u2018a\u011fr\u0131n\u0131n temel mekanizmas\u0131n\u0131 tedavi\u2019 etmek amac\u0131 ile kullan\u0131l\u0131rlar.” diye konu\u015ftu.<\/p>\n
A\u011fr\u0131n\u0131n kayna\u011f\u0131 net belirlenmeli
\n
D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc\u2019n\u00fcn (DS\u00d6) en hafif etkili ila\u00e7la ba\u015flayan \u00fc\u00e7 basamakl\u0131 a\u011fr\u0131 tedavi \u015femas\u0131 \u00f6nerdi\u011fini hat\u0131rlatan Prof. Dr. Tozan, ba\u015far\u0131l\u0131 tedavi i\u00e7in a\u011fr\u0131n\u0131n kayna\u011f\u0131n\u0131n \u00f6rne\u011fin: kas-iskelet sistemi, sinirsel, nosiseptif (doku hasar\u0131na neden olan bir yaralanmadan sonra hissedilen a\u011fr\u0131), n\u00f6ropatik (sinir hasar\u0131 ya da sinir sisteminde bir problem nedeni ile olu\u015fan bir a\u011fr\u0131 tipi), viseral a\u011fr\u0131 (genellikle yaralanma, iltihaplanma veya i\u015flev bozuklu\u011funun sonucu olan i\u00e7 organlardan kaynaklanan bir a\u011fr\u0131 t\u00fcr\u00fc) gibi net bir \u015fekilde belirlenmesi gerekti\u011fini s\u00f6yledi. Tan\u0131ya (kanser a\u011fr\u0131s\u0131, bel a\u011fr\u0131s\u0131, diyabetik n\u00f6ropatik a\u011fr\u0131 gibi) uygun analjezik se\u00e7ilmesinin \u00f6nemine de dikkat \u00e7eken Prof. Dr. Tozan s\u00f6zlerini \u015f\u00f6yle s\u00fcrd\u00fcrd\u00fc:
\n
“Kronik a\u011fr\u0131 tedavisinde; a\u011fr\u0131 kesiciler; \u2018a\u011fr\u0131m olduk\u00e7a al\u0131r\u0131m\u2019 \u015feklinde de\u011fil, belli bir s\u00fcre; \u2018a\u011fr\u0131 olsa da olmasa da\u2019 kural\u0131 ile devaml\u0131 ve belli bir s\u00fcrede al\u0131nmal\u0131d\u0131r. En d\u00fc\u015f\u00fck dozda ba\u015flay\u0131p etkili olan doza kadar titrasyon (yava\u015f yava\u015f doz art\u0131\u015f\u0131) yap\u0131lmal\u0131d\u0131r. Gereksiz uzun s\u00fcreli kullan\u0131mdan ka\u00e7\u0131n\u0131lmal\u0131d\u0131r. \u00d6zellikle opioid (beyin h\u00fccreleriyle etkile\u015fime giren geni\u015f bir a\u011fr\u0131 kesici ila\u00e7 grubu) analjeziklerin, kab\u0131zl\u0131k, bulant\u0131-kusma, bili\u015fsel fonksiyonlarda yava\u015flama, uykuya e\u011filim gibi yan etkileri olabilir. Ate\u015f ve hafif \/ orta \u015fiddette a\u011fr\u0131 tedavisinde kullan\u0131lan parasetamol \u00f6zellikle uzun s\u00fcreli ve y\u00fcksek dozlarda \u2018karaci\u011fer toksisitesi\u2019ne neden olabilir. A\u011fr\u0131 kesici kullan\u0131m\u0131nda yan etkilerine, di\u011fer ila\u00e7larla etkile\u015fimine ve kontrendikasyonlar\u0131na kar\u015f\u0131 dikkatli olunmal\u0131d\u0131r. Hekim, hastas\u0131na ilac\u0131 nas\u0131l, ne zaman ve ne kadar s\u00fcreyle kullanaca\u011f\u0131, yan etkileri konusunda bilgi vermelidir. Hastalar da hekimin verdi\u011fi bilgi ve uyar\u0131lar\u0131n\u0131 dikkate almal\u0131d\u0131r.”
\n
\u00d6te yandan Algoloji Profes\u00f6r\u00fc Tozan, hastan\u0131n a\u011fr\u0131 skoru ve ya\u015fam kalitesinin d\u00fczenli aral\u0131klarla de\u011ferlendirilmesi gerekti\u011fini, gerekiyorsa doz veya ila\u00e7 de\u011fi\u015fikli\u011fi yap\u0131lmas\u0131 gerekti\u011fini kaydetti. Kronik a\u011fr\u0131da multidisipliner yakla\u015f\u0131m\u0131n \u00f6nemine dikkat \u00e7eken Tozan, “Uzun s\u00fcreli a\u011fr\u0131da sadece ila\u00e7 de\u011fil, fizik tedavi, psikolojik destek, egzersiz, beslenme gibi destekleyici y\u00f6ntemler de uygulanmal\u0131d\u0131r.” dedi.
<\/p>\n","protected":false},"excerpt":{"rendered":"
Algolog Prof. Dr. Emine Nur Tozan, a\u011fr\u0131 kesicilerin do\u011fru kullan\u0131m\u0131n\u0131n tedavi ba\u015far\u0131s\u0131n\u0131 art\u0131rd\u0131\u011f\u0131n\u0131 s\u00f6yledi. Kronik a\u011fr\u0131 tedavisi g\u00f6ren pek \u00e7ok hastan\u0131n sadece a\u011fr\u0131lar\u0131 oldu\u011fu zaman a\u011fr\u0131 kesici kulland\u0131\u011f\u0131na dikkat \u00e7eken Prof. Dr. Tozan, “Kronik a\u011fr\u0131 tedavisinde a\u011fr\u0131 kesiciler; \u2018a\u011fr\u0131m olduk\u00e7a al\u0131r\u0131m\u2019 \u015feklinde de\u011fil, belli bir s\u00fcre; \u2018a\u011fr\u0131 olsa da olmasa da\u2019 kural\u0131 ile devaml\u0131 ve…<\/p>\n","protected":false},"author":1,"featured_media":46565,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-46564","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/46564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46564"}],"version-history":[{"count":1,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/46564\/revisions"}],"predecessor-version":[{"id":46566,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/46564\/revisions\/46566"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/media\/46565"}],"wp:attachment":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}